These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 2881873)

  • 81. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction.
    Thompson JJ; Zinsser KR; Enterline HT
    Hum Pathol; 1983 Jan; 14(1):42-61. PubMed ID: 6832749
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Sucrase-isomaltase gene expression in Barrett's esophagus and adenocarcinoma.
    Wu GD; Beer DG; Moore JH; Orringer MB; Appelman HD; Traber PG
    Gastroenterology; 1993 Sep; 105(3):837-44. PubMed ID: 8359653
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Reduced expression of αGlcNAc in Barrett's oesophagus adjacent to Barrett's adenocarcinoma--a possible biomarker to predict the malignant potential of Barrett's oesophagus.
    Iwaya Y; Hasebe O; Koide N; Kitahara K; Suga T; Shinji A; Muraki T; Yokosawa S; Yamada S; Arakura N; Tanaka E; Nakayama J
    Histopathology; 2014 Mar; 64(4):536-46. PubMed ID: 24117499
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Time gated fluorescence spectroscopy in Barrett's oesophagus.
    Ortner MA; Ebert B; Hein E; Zumbusch K; Nolte D; Sukowski U; Weber-Eibel J; Fleige B; Dietel M; Stolte M; Oberhuber G; Porschen R; Klump B; Hörtnagl H; Lochs H; Rinneberg H
    Gut; 2003 Jan; 52(1):28-33. PubMed ID: 12477755
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Barrett's oesophagus: from metaplasia to dysplasia and cancer.
    Fléjou JF
    Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i6-12. PubMed ID: 15711008
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Molecular biology of Barrett's cancer.
    Atherfold PA; Jankowski JA
    Best Pract Res Clin Gastroenterol; 2006; 20(5):813-27. PubMed ID: 16997163
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Gastric and intestinal differentiation in Barrett's metaplasia and associated adenocarcinoma.
    Chaves P; Cruz C; Dias Pereira A; Suspiro A; de Almeida JC; Leitão CN; Soares J
    Dis Esophagus; 2005; 18(6):383-7. PubMed ID: 16336609
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cancer risk in Barrett's oesophagus.
    Dias Pereira A; Suspiro A; Chaves P
    Eur J Gastroenterol Hepatol; 2007 Nov; 19(11):915-8. PubMed ID: 18049157
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Prevalence of Barrett's esophagus and expression of mucin antigens detected by a panel of monoclonal antibodies in Barrett's esophagus and esophageal adenocarcinoma in Japan.
    Azuma N; Endo T; Arimura Y; Motoya S; Itoh F; Hinoda Y; Irimura T; Hosokawa M; Imai K
    J Gastroenterol; 2000; 35(8):583-92. PubMed ID: 10955596
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metaplastic tissues of the distal oesophagus, oesophago-gastric junction and proximal stomach.
    Flucke U; Steinborn E; Dries V; Mönig SP; Schneider PM; Thiele J; Hölscher AH; Dienes HP; Baldus SE
    Histopathology; 2003 Aug; 43(2):127-34. PubMed ID: 12877727
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Adenocarcinoma in Barrett's esophagus. A clinicopathologic study of 65 cases.
    Streitz JM; Ellis FH; Gibb SP; Balogh K; Watkins E
    Ann Surg; 1991 Feb; 213(2):122-5. PubMed ID: 1992937
    [TBL] [Abstract][Full Text] [Related]  

  • 92. The metabolic marker tumour pyruvate kinase type M2 (tumour M2-PK) shows increased expression along the metaplasia-dysplasia-adenocarcinoma sequence in Barrett's oesophagus.
    Koss K; Harrison RF; Gregory J; Darnton SJ; Anderson MR; Jankowski JA
    J Clin Pathol; 2004 Nov; 57(11):1156-9. PubMed ID: 15509675
    [TBL] [Abstract][Full Text] [Related]  

  • 93. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
    Endzinas Z; Mickevicius A; Kiudelis M
    Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Superficial adenocarcinoma of the oesophagus arising in Barrett's mucosa with dysplasia: a clinico-pathological study of 12 patients.
    De Baecque C; Potet F; Molas G; Flejou JF; Barbier P; Martignon C
    Histopathology; 1990 Mar; 16(3):213-20. PubMed ID: 2332206
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus.
    Agnese V; Cabibi D; Calcara D; Terrasi M; Pantuso G; Fiorentino E; Intrivici C; Colucci G; Aragona F; Gebbia N; Bazan V; Russo A
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi110-5. PubMed ID: 17591802
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Vitamin D receptor expression in the mucosal tissue at the gastroesophageal junction.
    Trowbridge R; Mittal SK; Sharma P; Hunter WJ; Agrawal DK
    Exp Mol Pathol; 2012 Oct; 93(2):246-9. PubMed ID: 22664272
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cyclo-oxygenase-2 expression in Barrett's oesophageal carcinogenesis: an immunohistochemical study.
    Cheong E; Igali L; Harvey I; Mole M; Lund E; Johnson IT; Rhodes M
    Aliment Pharmacol Ther; 2003 Feb; 17(3):379-86. PubMed ID: 12562450
    [TBL] [Abstract][Full Text] [Related]  

  • 98. How does inflammation cause Barrett's metaplasia?
    Colleypriest BJ; Ward SG; Tosh D
    Curr Opin Pharmacol; 2009 Dec; 9(6):721-6. PubMed ID: 19828375
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The frequency of glassy cells in Barrett's mucosa: a study in Baboons.
    Rubio CA; Dick EJ; Orrego A; Hubbard GB
    In Vivo; 2009; 23(6):925-7. PubMed ID: 20023234
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Adenocarcinoma in Barrett's oesophagus. Two case reports and discussion.
    Hall C; Høie J; Langmark F
    Scand J Thorac Cardiovasc Surg; 1982; 16(1):107-9. PubMed ID: 7071541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.